Routine

Microscopic colitis (collagenous & lymphocytic colitis)

Collagenous colitis, lymphocytic colitis, chronic watery diarrhoea, budesonide · Gastroenterology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Chronic non-bloody watery diarrhoea with a macroscopically normal/near-normal colonoscopy but diagnostic histology (collagenous: thickened subepithelial collagen band; lymphocytic: raised intraepithelial lymphocytes). Typically older women; associated with coeliac disease, autoimmune conditions, and drugs (NSAIDs, PPIs, SSRIs). Diagnosis requires colonic biopsies.

Red flags

  • Rectal bleeding (atypical - reconsider diagnosis/IBD or malignancy)
  • Weight loss, nocturnal diarrhoea with dehydration
  • Severe dehydration / electrolyte disturbance from high-volume diarrhoea
  • New anaemia

Assessment

Differential diagnosis

  • Irritable bowel syndrome (IBS-D)
  • Coeliac disease (frequently coexists - test)
  • Bile acid diarrhoea
  • Inflammatory bowel disease
  • Infective / post-infective diarrhoea
  • Drug-induced diarrhoea (NSAIDs, PPIs, SSRIs, metformin)
  • Hyperthyroidism, carcinoid, VIPoma (secretory)

Investigations

  • Colonoscopy with MULTIPLE segmental biopsies (right AND left colon) - mucosa often looks normal; diagnosis is histological
  • Coeliac serology (tTG-IgA) - strong association
  • FBC, CRP, U&E, TFTs, ferritin
  • Stool studies to exclude infection (incl. C. difficile) and faecal calprotectin
  • Review drug history for culprits (NSAIDs, PPIs, SSRIs, ranitidine, acarbose)
  • Consider bile acid diarrhoea testing if incomplete response

Management

  • Confirm diagnosis histologically and exclude coeliac disease
  • Stop culprit drugs where possible (NSAIDs, PPIs, SSRIs)
  • General measures: avoid caffeine/lactose if aggravating; antidiarrhoeal for mild symptoms
  • Induce remission with oral budesonide (first-line, most effective)
  • Taper budesonide after 6-8 weeks; many relapse
  • For frequent relapse: low-dose maintenance budesonide at lowest effective dose
  • Refer gastroenterology for refractory disease (immunomodulators/biologics rarely needed)

Drugs & doses

Budesonide 9 mg PO once daily for 6-8 weeks to induce remission, then taper (first-line - highest-quality evidence)
Maintenance (frequent relapse): budesonide 3-6 mg PO daily, lowest effective dose
Loperamide 2 mg PO PRN/after loose stool for mild symptoms or as adjunct
Colestyramine 4 g PO daily-BD if coexisting bile acid diarrhoea
Stop culprit drugs (NSAIDs, PPIs, SSRIs) - may alone resolve symptoms
Refractory: thiopurine or anti-TNF per specialist (rare) [verify local]

Disposition

Outpatient gastroenterology. Admit only for severe dehydration/electrolyte derangement.

Complications & pitfalls

  • Dehydration and electrolyte disturbance
  • Significant quality-of-life impairment
  • Frequent relapse requiring long-term budesonide (bone/metabolic monitoring)
  • Rare colonic perforation (collagenous colitis, usually post-procedure)

Exam pearls

  • Think microscopic colitis in an OLDER WOMAN with chronic watery non-bloody diarrhoea and a normal-looking colonoscopy - the diagnosis is only made on biopsy, so biopsy the normal-looking colon.
  • Budesonide 9 mg/day is the clear first-line therapy for induction (AGA/BSG) - it is far more effective than loperamide alone.
  • Always test for and treat coexisting coeliac disease, and stop drug triggers (NSAIDs, PPIs, SSRIs).
  • Relapse after budesonide withdrawal is common - low-dose maintenance budesonide is acceptable with bone monitoring.
  • If diarrhoea persists on budesonide, reconsider coexisting bile acid diarrhoea or an alternative diagnosis.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.